Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-05-07

FDA Approved: CEFDINIR — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Lupin Pharmaceuticals' supplemental application for CEFDINIR, a generic cefdinir product, authorizing continued/expanded marketing under the AN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefdinir (cefdinir)

Snippet

SUPPL AP for CEFDINIR (CEFDINIR)